toxylact: a07bc01 pectin

The first professional lActological database in the word

Pectin (ATC A07BC01) is a non‑absorbed intestinal adsorbent and demulcent used in some antidiarrheal and gut‑protective preparations, with negligible systemic absorption and a very low expected risk during breastfeeding.ebi+3

ATC A07BC01 overview

ATC code A07BC01 designates pectin within the subgroup “Other intestinal adsorbents” (A07BC), itself part of the intestinal adsorbents class A07B among antidiarrheals. In clinical products it is often combined with kaolin (A07BC02) in kaolin‑pectin suspensions used historically to treat acute diarrhea.ebi+5

Pharmacology and mechanism

Pectin is a plant‑derived polysaccharide (soluble fiber) that forms a viscous gel in the intestinal lumen, coating the mucosa and binding water, bacteria, and toxins. This demulcent and adsorbent action can increase stool consistency and reduce irritation, though in vitro data suggest only modest endotoxin‑binding capacity compared with some other adsorbents.pubmed.ncbi.nlm.nih+3

Therapeutic indications

Within A07BC01, pectin—usually as part of pectin‑kaolin mixtures—is indicated as a symptomatic treatment for acute, self‑limited diarrhea and as a gastrointestinal protectant. These products are generally available without prescription and are used as adjuncts to oral rehydration rather than substitutes for fluid and electrolyte therapy.drugs+2

Pharmacokinetics relevant to lactation

Pectin is considered to have “zero bioavailability,” remaining within the gastrointestinal tract without significant absorption and being excreted in the feces. Because it does not enter the maternal circulation to a meaningful extent, it is not expected to be excreted into breast milk in measurable amounts.drugs.ncats+1

Maternal safety profile

Oral pectin‑containing antidiarrheals are usually well tolerated; constipation is the principal adverse effect, particularly with frequent or high‑dose use. Serious systemic side effects have not been reported with standard dosing, although persistent diarrhea, fever, or blood in stools should prompt medical evaluation rather than continued self‑treatment.ams.usda+2

Lactation safety assessment

Specialized lactation resources classify pectin as compatible with breastfeeding and “not risky for breastfeeding or infant,” based on its lack of intestinal absorption and absence of excretion into milk. Because gastrointestinal medications for diarrhea are typically used short‑term, this non‑absorbed profile further supports a very low‑risk categorization during lactation.pubmed.ncbi.nlm.nih+1

Potential effects on the breastfed infant

Direct exposure of the infant to pectin via breast milk is expected to be negligible, so pectin‑related toxicity or interference with nutrient absorption in the infant is highly unlikely. Any infant risk is more likely to stem from the underlying maternal illness (for example infectious diarrhea) or from co‑formulated agents (such as kaolin or bismuth in certain legacy products), which should be evaluated separately.drugs.ncats+3

Practical use in breastfeeding women

For breastfeeding mothers with mild, self‑limited diarrhea, first‑line management remains oral rehydration and dietary measures, with modern guidelines often preferring agents such as loperamide when drug therapy is needed. Where pectin or kaolin‑pectin preparations are used, they can generally be taken during breastfeeding without altering feeding schedules, while monitoring both mother and infant for persistence or worsening of diarrheal symptoms.pubmed.ncbi.nlm.nih+5

Role among intestinal adsorbents

Compared with other intestinal adsorbents, pectin has a long record of use and an excellent lactation safety profile, but current evidence suggests limited efficacy, and it is no longer recommended as a first‑line agent for non‑infectious diarrhea in many guidelines. Its favorable toxico‑lactological profile therefore needs to be balanced against clinical effectiveness, with preference given to treatments that combine proven efficacy with similarly low risk in breastfeeding.pubmed.ncbi.nlm.nih+4

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.